In breast cancer, disintegrin and metalloproteinase domain-containing protein 12 (ADAM12) is one of the members of MMP family, which its overexpression could increase angiogenesis through epidermal growth factor receptor (EGFR)/STAT3/AKT in BC [41]. This evidence concerns the gene EGFR and breast carcinoma.